InvestorIntel Features on Scythian Biosciences Corp.
November 14, 2017
Cannabinoids, the diverse compounds which bind to the homonymous receptors in the human body, are only recently being properly explored, […]
August 29, 2017
Jonathan Gilbert, CEO and Director, and David Schrader, COO of Scythian Biosciences Corp. (TSXV: SCYB) (“Scythian”) in an interview with […]
August 14, 2017
Scythian BioSciences Corp. (TSXV: SCYB), which began trading on the TSXV last week under the symbol SCYB, is developing cannabinoid-based drugs to […]